Although the activation of cannabinoid receptor-1 (CB1) receptors by cannabinoids is known to inhibit neuronal hyperexcitability and reduce excitotoxic cell death, the mechanistic links between these two actions remain elusive. We tested the hypothesis that activation of CB1 receptors inhibits N-methyl-Daspartic acid (NMDA)-mediated calcium influx and cell death via the inositol triphosphate (IP 3 ) signaling pathway in both primary dorsal root ganglia neurons and a cultured neuronal cell line (F-11 cells). These cells were pretreated with the cannabi-,212-2; WIN) before exposure to NMDA. Concentrations of cytosolic calcium were measured with the ratiometric calcium indicator, Fura-2, and cell death was determined by a cell viability test. WIN dose-dependently attenuated both the calcium influx and cell death induced by NMDA. These effects were blocked by selective cannabinoid CB1 receptor antagonistsIt is interesting to note that a transient Ca 2ϩ signal was observed after the acute application of WIN. This Ca 2ϩ increase was blocked by a CB1 receptor antagonist AM251, IP 3 receptor antagonist 2-aminoethyl diphenylborinate, or by depleting intracellular Ca 2ϩ stores with the endoplasmic reticulum Ca 2ϩ pump inhibitor thapsigargin. Removal of extracellular Ca 2ϩ , on the other hand, had no effect on the CB1 receptor-induced Ca 2ϩ increase. These data suggest that WIN triggers a cascade of events: it activates the CB1 receptor and the IP 3 signaling pathway, stimulates the release of Ca 2ϩ from intracellular stores, raises the cytosolic Ca 2ϩ levels, and inhibits the NMDAmediated Ca 2ϩ influx and cell death through a process that remains to be determined.Cannabinoid receptors are members of the superfamily of G i /G o -coupled receptors and include at least two subtypes, Cannabinoid receptor-1 (CB1) and CB2 receptors. The CB1 receptor is expressed primarily in the central nervous system (Matsuda et al., 1990) and peripheral nociceptors (Agarwal et al., 2007), whereas the CB2 receptor is predominantly expressed in immune cells (Munro et al., 1993) and is also detectable in brainstem neurons (Van Sickle et al., 2005) and spinal cord . More recently, another cannabinoid receptor GPR55 was identified that appears to be highly expressed in large dorsal root ganglion neurons